ACUTE MYELOID LEUKEMIA, IN RELAPSE
Clinical trials for ACUTE MYELOID LEUKEMIA, IN RELAPSE explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA, IN RELAPSE trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA, IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune cell therapy targets tough childhood leukemia
Disease control TerminatedThis study tested a new treatment for children and young adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack leukemia cells. The ma…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated May 05, 2026 11:52 UTC
-
Promising leukemia drug trial cut short — only 10 patients enrolled
Disease control TerminatedThis study tested a drug called PF-05212384 in people with certain aggressive blood cancers (leukemia or related conditions) that came back or didn't respond to treatment. The goal was to see if the drug could shrink or control the cancer. Only 10 people took part before the stud…
Matched conditions: ACUTE MYELOID LEUKEMIA, IN RELAPSE
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 04, 2026 16:21 UTC